Neochem Bio Solutions Limited (NSE:NEOCHEM)

India · Delayed Price · Currency is INR

93.90

-1.35 (-1.42%)

At close: Sep 7, 2026

Market Cap	1.67B
Revenue (ttm)	1.11B +123.3%
Net Income	120.27M +1,143.2%
EPS	8.71
Shares Out	17.12M
PE Ratio	11.17
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	21,600
Open	97.00
Previous Close	95.25
Day's Range	93.50 - 97.00
52-Week Range	63.00 - 121.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 8, 2026

About Neochem Bio Solutions

Neochem Bio Solutions Limited engages in the manufacturing and sale of specialty performance chemicals in India and internationally. It offers polymers under the EVENOL, AMPINOL, DYFAST, KOLAPSOL, PRIMAPRINT, TRUTONE, BRILLOPRINT, AMBITAC, and AQUATREAT brand names; surfactants under the KLARIZYM, KLARITOL, QUNOX, LUBIMAX, NEUTRAX, MERCOL, and FABSAFE brands; silicones under the GLIDEX and PRESTOFIN brand names; and esters and bio-based sustainable solutions under the REVLION and ASTASOFT. The company’s products are used in textile and garment,... [Read more]

Industry Chemicals and Allied Products

Founded 1978

Employees 65

Stock Exchange National Stock Exchange of India

Ticker Symbol NEOCHEM

Full Company Profile

Financial Performance

In fiscal year 2026, Neochem Bio Solutions's revenue was 1.11 billion, an increase of 31.51% compared to the previous year's 841.73 million. Earnings were 120.27 million, an increase of 61.64%.

Financial Statements